Open | 0.64 |
Previous Close | 0.62 |
Day Range | 0.63 - 0.64 |
52-Week Range | 0.62 - 2.43 |
All-Time High | 63.62 |
Avg. Volume (50-day) | 368,575.62 |
EPS (TTM) | -1.7018 |
Next Earnings Date | 2025-05-08 (AMC) |
Last Earnings Date | 2025-03-20 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | Yes |
P/E Ratio | -0.3600 |
PEG Ratio | - |
Price to Book | 0.80 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | - |
Revenue per Share (TTM) | - |
Shares Outstanding | 124.852 M |
Share Float (%) | 76.79 M |
% Held by Institutions | 43.00 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 0.84 (-25.00%) |
+/- SMA(50) | 1.12 (-43.75%) |
+/- SMA(200) | 0.98 (-35.71%) |
5-Day Perf. | -22.22% |
1-Month Perf. | -41.67% |
3-Month Perf. | -43.75% |
6-Month Perf. | -4.47% |
YTD Perf. | -43.24% |
1-Year Perf. | -69.86% |
RSI(14) | 25.92 |
ATR(14) | 0.08 |
ADX(14) | 31.19 |
Beta (5Y) | 1.34 |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.
VOR has triggered the following predefined scans:
P&F Double Bottom Breakdown |
Filled Black Candles |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.